The Cancer Consortium provides a variety of funding opportunities for the purpose of supporting existing members and recruiting new ones, with the ultimate goal of stimulating innovative cancer research. Opportunities include Pilot Awards, New Investigator Awards, and Catchment Area Health Pilot Awards.
Consortium developmental awards are funded through a combination of Cancer Center Support Grant (CCSG) funds and philanthropic donations. Applications for each award are evaluated by a committee of Consortium faculty reviewers.
Eligibility and application requirements are different for each award. For more information, please review the description and RFA for each individual award.
To be notified of CCSG administrative supplement opportunities, please subscribe to our distribution list. If you are already a Consortium member, you should automatically receive funding opportunity announcements.
Funds are available from the Fred Hutch/University of Washington Cancer Consortium (“The Consortium”) Cancer Center Support Grant (CCSG) to support cancer-related pilot projects. This competition will provide awards of up to $100,000 direct costs (plus F&A/indrect costs as allowable) for one year of pilot project support.
Release date — January 4, 2023
Due date — February 27, 2023
Request for Applications - 2023 Cancer Consortium Pilot Awards
Follow the instructions in the RFA to submit your application via Fred Hutch's Funding Portal.
Please contact Dr. Kris Blair (kblair@fredhutch.org) with questions.
Funds are available from the Fred Hutch/University of Washington Cancer Consortium ("The Consortium") Cancer Center Support Grant (CCSG) to provide developmental support to new or junior faculty who are establishing their research within the Consortium. These funds provide a flexible source of funding designed to allow new investigators to work toward obtaining future, independent research funding.
This competition will provide five to six awards of up to $80,000 direct costs. Full facilities and administrative costs as allowable will be awarded in addition to this amount.
Release date — May 4, 2022
Due date — June 17, 2022
Request for Applications – 2022 Cancer Consortium New Investigator Awards
Applications are to be submitted as one complete PDF file to: cancerconsortium@fredhutch.org.
Contact Heidi Tham, Assistant Director of Administration, with questions at hharbach@fredhutch.org.
Funds are available from the Fred Hutch/University of Washington Cancer Consortium (Consortium)’s Cancer Center Support Grant (CCSG) and non-sponsored funds to support new cancer-related pilot projects or research directions focused on the Consortium’s catchment area, which now includes the entire state of Washington. Please see page 1 of RFA for more information about the cancer burden in the catchment area.
The research plan should address research on cancers relevant to the catchment area and/or the populations that face the highest burden or cancer disparities in the state. Please see pages 1-2 of the RFA. This competition will fund at least one project, at a minimum of $80,000 in direct costs, for one year.
Consortium members are eligible for this pilot funding. Only one Principal Investigator applicant per Cancer Consortium Research Program will be accepted (see section “B. Application Format – Page limits and attachments #1” for more details).
Release date — January 19, 2023
Due date — February 28, 2023
To apply, please submit the PDF file containing your application (included in the RFA) and letter of support to to the Office of Community Outreach & Engagement via e-mail at EndDisparities@fredhutch.org.
Cancer Consortium Catchment Area Health Pilot Award RFA 2023 - PDF
FDP-Expanded-Clearinghouse-Letter-of-Intent-Fred-Hutch (PDF)
Contact the Office of Community Outreach and Engagement (OCOE) with questions at EndDisparities@FredHutch.org.
Funds are available from Safeway, Inc. to support cancer-related pilot projects with awards of at least $80,000 direct costs (F&A not included) for one year of pilot project support. Fred Hutch early career investigators who are Consortium members are eligible for this funding opportunity.
There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged.
More details about the application process can be found in the RFA.
Release date — September 26, 2022
Due date — October 21, 2022 at 5 pm
Request for Applications - 2022 Cancer Consortium Pilot Awards (PDF)
Request for Applications - 2022 Cancer Consortium Pilot Awards (Word)
Applications are to be submitted as one complete PDF file to: cancerconsortium@fredhutch.org
Contact Kris Blair, Research Development Specialist, with questions at kblair@fredhutch.org.
The Cancer Consortium Survivorship Program https://www.fredhutch.org/survivorship) invites proposals of high impact and innovation that will promote new research directions focused on cancer survivors. The goal of this award is to stimulate cross-institutional collaborations (Fred Hutch, UW, Seattle Children’s) and/or new collaborations between Consortium investigators who have not previously worked together.
Due date: January 31, 2022 (awardees will be announced no later that February 28, 2022)
Contact Dr. Eric Chow, Co-Director of the Fred Hutch Survivorship Program, with questions at ericchow@uw.edu.
Member | Research Program | Award Institution |
Kemi Doll, MD, MCSR^* |
Breast & Ovary Cancers |
UW |
Philip Greenberg, MD^ |
Cancer Immunology |
FH |
Heather Greenlee, ND, PhD, MPH |
Cancer Epidemiology, Prevention & Control |
FH |
Patrick Paddison, PhD |
Cancer Basic Biology |
FH |
Raymond Yeung, MD, FRCS(C), FACS^ |
Other Oncology |
UW |
Member | Research Program | Award Institution |
Richard Adeyemi, DVM, PhD |
Breast & Ovary Cancers |
FH |
Brittany Barber, MD, MSc, FRCSC |
Other Oncology |
UW |
Thelma Escobar |
Cancer Basic Biology |
UW |
Benham Nabet, PhD |
Cancer Basic Biology |
FH |
Yaw Nyame |
Prostate Cancer |
UW |
Member | Research Program | Award Institution |
Neelendu Dey, MD++ |
Pathogen Associated Malignancies |
FH |
Maitreya Dunham, PhD |
Cancer Basic Biology |
UW |
Mark Headley, PhD |
Cancer Immunology |
FH |
David Hockenbery, MD++ |
Cancer Basic Biology |
FH |
David MacPherson, PhD |
Cancer Basic Biology |
FH |
Margaret M. Madeleine, MPH, PhD* |
Pathogen Associated Malignancies |
FH |
Manoj Menon, MD, MPH++ |
Pathogen Associated Malignancies |
FH |
Evan Newell, PhD |
Cancer Immunology |
FH |
Lawrence D. True, MD^ |
Prostate Cancer |
UW |
Member | Research Program | Award Institution |
Kalyan Banda, MD |
Breast & Ovary Cancers |
UW |
Kevin Barry, PhD |
Cancer Immunology |
FH |
Nicolas Lehrbach, PhD |
Cancer Basic Biology |
FH |
Shannon Oda, PhD |
Cancer Immunology |
SC |
Shivani Srivastava, PhD |
Cancer Immunology |
FH |
Diane Tseng, MD, PhD |
Other Oncology |
UW |
Member | Research Program | Award Institution |
Marianna Dubard-Gault, MD* ++ |
Other Oncology |
UW |
Teresa Hyun MD, PhD^^ ++ |
Hematologic Malignancies |
FH |
Savannah Partridge, PhD |
Breast & Ovary Cancers |
UW |
Kerryn Reding, PhD, MPH^^ |
Cancer Epidemiology, Prevention & Control |
UW |
Parth Shah, PharmD, PhD++ |
Cancer Epidemiology, Prevention & Control |
FH |
Alpana Waghmare, MD |
Hematologic Malignancies |
SC |
Member | Research Program | Award Institution |
Stacey Cohen, MD |
Other Oncology |
UW |
Brandon Hadland, MD, PhD |
Hematologic Malignancies |
FH |
Michael Haffner, MD, PhD |
Prostate Cancer |
FH |
Natasha Hunter, MD* |
Breast & Ovary Cancers |
UW |
Stanley Lee, PhD^ |
Hematologic Malignancies |
FH |
Yasemin Sancak, PhD |
Other Oncology |
UW |
Member | Research Program | Award Institution |
Brandon Dyer, MD |
Other Oncology |
UW |
Julie Mathieu, PhD |
Cancer Basic Biology |
UW |
Jeff Rasmussen, PhD |
Cancer Basic Biology |
UW |
Lucas Sullivan, PhD |
Cancer Basic Biology |
FH |
Trang VoPham, PhD, MS, MPH |
Cancer Epidemiology, Prevention & Control |
FH |
Member | Research Program | Award Institution |
Shreeram Akilesh, MD, PhD |
Cancer Basic Biology |
UW |
Rachel Ceballos, PhD* |
Cancer Epidemiology, Prevention & Control |
FH |
Eric Chow, MD, MPH++ |
Hematologic Malignancies |
FH |
Member | Research Program | Award Institution |
Taran Gujral, PhD |
GI Cancer/Prostate Cancer |
FH |
Anna Halpern, MD |
Hematologic Malignancies |
UW |
Salene Jones, PhD |
Cancer Epidemiology, Prevention & Control |
FH |
Scott Kennedy, PhD |
Cancer Basic Biology |
UW |
John Lee, MD, PhD |
Prostate Cancer |
FH |
Kathryn Lowry, MD |
Cancer Epidemiology, Prevention & Control |
UW |
Parth Shah, PharmD, PhD* |
Cancer Epidemiology, Prevention & Control |
FH |
David Shechner, PhD |
Cancer Basic Biology |
UW |
Member | Research Program | Award Institution |
Susan Bullman, PhD |
Global Oncology |
FH |
Heather Gustafson, PhD |
Cancer Immunology |
SC |
Gavin Ha, PhD |
Biostatistics & Computational Biology |
FH |
Teresa Kim, MD |
Other Oncology |
UW |
Member | Research Program | Award Institution |
Eric Huang, MD, PhD |
Other Oncology |
UW |
Sarah Psutka, MD |
Prostate Cancer |
UW |
Roland Walter, MD, PhD, MS |
Hematologic Malignancies |
UW |
Member | Research Program | Award Institution |
Jonathan Bricker, PhD* |
Cancer Epidemiology, Prevention & Control |
FH |
Luis Ceze, PhD |
Cancer Basic Biology |
UW |
Eleanor Chen, MD, PhD |
Cancer Basic Biology |
UW |
John Gore, MD++ |
Prostate Cancer |
UW |
Janie Lee, MD++ |
Cancer Epidemiology, Prevention & Control |
UW |
Karen Syrjala, PhD |
Hematologic Malignancies |
FH |
Raymond Yeung, MD, FRCS(C), FACS |
GI Cancer |
UW |
Member | Research Program | Award Institution |
Slobodan Beronja, PhD |
Cancer Basic Biology |
FH |
Cole DeForest, PhD |
Cancer Basic Biology |
UW |
VK Gadi, MD, PhD |
Women’s Cancer |
FH |
Liangcai Gu, PhD |
Cancer Basic Biology |
UW |
Andrea Hartzler, PhD |
Prostate Cancer |
UW |
Jaimee Heffner, PhD++ |
Cancer Epidemiology, Prevention & Control |
FH |
James Park, MD |
GI Cancer |
UW |
Supriya Saha, MD |
GI Cancer |
FH |
Member | Research Program | Award Institution |
Neelendu Dey, MD |
GI Cancer |
FH |
Rachel Issaka, MD |
Cancer Epidemiology, Prevention & Control |
FH |
Vandana Kalia, PhD |
Immunology & Vaccine Development |
SC |
Masaoki Kawasumi, MD, PhD |
Cancer Basic Biology |
UW |
Bo Yu, MD |
Women’s Cancer |
UW |
Member | Research Program | Award Institution |
William DePaolo, PhD |
GI Cancer |
UW |
Phuong Vo, MD |
Hematologic Malignancies |
FH |